Pages
Products
LacZ Adeno-associated virus(AAV Serotype 2)

LacZ Adeno-associated virus(AAV Serotype 2)

Cat.No. :  AAV00026Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 2 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Gene Informationn

Cat. No. AAV00026Z
Description LacZ Adeno-associated virus(AAV Serotype 2) which expresses β-galactosidase (LacZ) under CMV promoter. LacZ is frequently used as reporter gene. This is achieved by staining the tissues or cells with substrates like X-gal, which produces a blue color in the presence of beta-galactosidase.
Reporter LacZ
Serotype AAV Serotype 2
Product Type Adeno-associated virus
Application

1. Determination of optimal MOI (multiplicity of infection), administration methods etc.

2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue.

3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery.

Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Gene Name
Gene Symbol
Synonyms
Gene ID
Pathway
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

LacZ Adeno-associated virus (AAV) serotype 2 is a widely used viral vector in genetic research and therapy. AAV is a small, non-enveloped virus belonging to the Parvoviridae family. AAV is replication-defective, does not cause inflammation, and does not cause human disease. Among the various serotypes, AAV2 has been the most extensively studied due to its versatility and ability to transduce a variety of cell types. AAV2 is able to stably deliver genes to ocular tissues such as the retina and uvea, and has low immunogenicity. Therefore, AAV2 is widely used in gene therapy for inherited retinal diseases, such as Leber hereditary retinopathy (LCA) and cone-cell atrophy. The LacZ gene is often included in AAV2 vectors as a reporter gene. LacZ encodes the enzyme β-galactosidase, which hydrolyzes lactose into glucose and galactose. Researchers use LacZ as a marker to track gene expression, vector distribution, and successful transduction in host cells. The presence of LacZ enables scientists to histochemically stain cells and tissues with X-gal, a substrate that turns blue upon enzymatic cleavage, thereby visualizing the extent and location of gene expression.

Transplantation of cells into the infarcted heart has the potential to improve myocardial recovery significantly. However, the low efficiency of cell implantation still limits the therapeutic efficacy. Here, researchers report the results of competitive screening of most known chemokines and interleukins to assess their ability to promote cardiac engraftment of bone marrow (BM)-derived MSCs and to rank their relative efficacy. This competitive implant screen was performed by adapting the in vivo functional selection (FunSel) method. FunSel is based on the use of a panel of secreted factors, each encoded by a different adeno-associated virus (AAV) vector. Here, mixed preparations of these vectors were used to transduce MSCs in vitro and then transplant them into the heart under normal and ischemic conditions. By ranking 80 different cytokines and growth factors for their ability to stimulate heart engraftment by mesenchymal stromal cells, cardiotrophin-1 (Ctf1) was found to be the most potent factor in both normal and infarcted hearts. Enhanced engraftment of Ctf1-preconditioned mesenchymal stromal cells was mediated by the rapid activation of the focal adhesion complexes of the cells.

Proper adhesion to the extracellular matrix is known to be a major determinant of cell survival in many experimental settings and appears to be particularly important following cell transplantation in environments of hypoxia and high oxidative stress levels, such as the infarcted myocardium. Indeed, the researchers found that Ctf1 protected BM-MSCs from oxidative damage. Cells were treated with hydrogen peroxide after transduction with AAV2-Ctf1 or pretreated with rCtf1. In both cases, the number of apoptotic cells (quantified by terminal deoxynucleotidyl transferase dUTP nick end labeling positivity) was reduced by more than 2.5-fold compared to the corresponding controls (transduction with AAV2-LacZ or untreated cells, respectively; Figures 1A and 1B are representative images and quantification, respectively). Caspase 3/7 activation was also measured in cells treated with rCtf1 and this apoptotic marker was similarly reduced (Figure 1C).

Cardiotrophin-1 (Ctf1) protects bone marrow–derived mesenchymal stromal cells (BM-MSCs) from apoptosis.Figure 1. Cardiotrophin-1 (Ctf1) protects bone marrow–derived mesenchymal stromal cells (BM-MSCs) from apoptosis. (Bortolotti F, et al., 2017)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Outstanding product

I’ve been using the LacZ AAV Serotype 2 for my gene delivery studies, and the results have been outstanding.

Canada

03/30/2020

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction